EDGAR Filing Documents for 0001193125-11-271825

Form S-1 - General form for registration of securities under the Securities Act of 1933:

SEC Accession No. 0001193125-11-271825

Filing Date

2011-10-14

Accepted

2011-10-14 16:55:26

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-1	d237820ds1.htm	S-1	2390462
2	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION	d237820dex31.htm	EX-3.1	80765
3	AMENDED AND RESTATED BYLAWS	d237820dex33.htm	EX-3.3	136356
4	AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT	d237820dex42.htm	EX-4.2	202729
5	FORM OF COMMON STOCK WARRANT	d237820dex43.htm	EX-4.3	63937
6	FORM OF SERIES B PREFERRED STOCK WARRANT	d237820dex44.htm	EX-4.4	79163
7	CONVERTIBLE NOTE LOAN AGREEMENT	d237820dex45.htm	EX-4.5	48799
8	AMENDED AND RESTATED 1997 STOCK OPTION /STOCK ISSUANCE PLAN	d237820dex101.htm	EX-10.1	76648
9	AMENDED AND RESTATED 2002 EQUITY INCENTIVE PLAN	d237820dex102.htm	EX-10.2	78238
10	AMENDED AND RESTATED EMPLOYMENT AGREEMENT - THOMAS J. SCHALL, P.H.D.	d237820dex106.htm	EX-10.6	79317
11	AMENDED AND RESTATED EMPLOYMENT AGREEMENT - MARKUS J. CAPPEL, P.H.D.	d237820dex107.htm	EX-10.7	79817
12	AMENDED AND RESTATED EMPLOYMENT AGREEMENT - SUSAN M. KANAYA	d237820dex108.htm	EX-10.8	79554
13	AMENDED AND RESTATED EMPLOYMENT AGREEMENT - JUAN C. JAEN, P.H.D.	d237820dex109.htm	EX-10.9	79993
14	AMENDED AND RESTATED EMPLOYMENT AGREEMENT - PETRUS BEKKER M.D., P.H.D.	d237820dex1010.htm	EX-10.10	77621
15	STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE	d237820dex1011.htm	EX-10.11	222563
16	PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT	d237820dex1012.htm	EX-10.12	808229
17	AMENDMENT NO.1 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT	d237820dex1013.htm	EX-10.13	92490
18	AMENDMENT NO.2 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT	d237820dex1014.htm	EX-10.14	14962
19	AMENDMENT NO.3 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT	d237820dex1015.htm	EX-10.15	22426
20	AMENDMENT NO.4 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT	d237820dex1016.htm	EX-10.16	37774
21	AMENDMENT NO.5 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT	d237820dex1017.htm	EX-10.17	14957
22	AMENDMENT TO SERIES D PREFERRED STOCK SUBSCRIPTION AGREEMENT	d237820dex1019.htm	EX-10.19	14946
23	SERIES E PREFERRED STOCK SUBSCRIPTION AGREEMENT	d237820dex1020.htm	EX-10.20	104390
24	LOAN AND SECURITY AGREEMENT	d237820dex1021.htm	EX-10.21	133095
25	AMENDMENT NO.2 TO LOAN AND SECURITY AGREEMENT	d237820dex1022.htm	EX-10.22	37645
26	SUBSIDIARIES OF REGISTRANT	d237820dex211.htm	EX-21.1	1575
27	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	d237820dex231.htm	EX-23.1	1444
28	GRAPHIC	g237820g14z62.jpg	GRAPHIC	31793
29	GRAPHIC	g237820g48v96.jpg	GRAPHIC	73656
30	GRAPHIC	g237820g68b14.jpg	GRAPHIC	39974
31	GRAPHIC	g237820g76d82.jpg	GRAPHIC	22437
32	GRAPHIC	g237820g87n20.jpg	GRAPHIC	35173
	Complete submission text file	0001193125-11-271825.txt		5341315

Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043

Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900

ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)